KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Total Non-Current Liabilities (2016 - 2025)

Edwards Lifesciences has reported Total Non-Current Liabilities over the past 17 years, most recently at $2.9 billion for Q4 2025.

  • Quarterly results put Total Non-Current Liabilities at $2.9 billion for Q4 2025, up 9.08% from a year ago — trailing twelve months through Dec 2025 was $2.9 billion (up 9.08% YoY), and the annual figure for FY2025 was $2.9 billion, up 9.08%.
  • Total Non-Current Liabilities for Q4 2025 was $2.9 billion at Edwards Lifesciences, up from $2.7 billion in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for EW hit a ceiling of $3.0 billion in Q3 2024 and a floor of $2.2 billion in Q2 2022.
  • Median Total Non-Current Liabilities over the past 5 years was $2.5 billion (2021), compared with a mean of $2.5 billion.
  • Biggest five-year swings in Total Non-Current Liabilities: rose 16.61% in 2021 and later fell 10.95% in 2025.
  • Edwards Lifesciences' Total Non-Current Liabilities stood at $2.4 billion in 2021, then increased by 2.51% to $2.5 billion in 2022, then increased by 7.49% to $2.6 billion in 2023, then dropped by 0.93% to $2.6 billion in 2024, then increased by 9.08% to $2.9 billion in 2025.
  • The last three reported values for Total Non-Current Liabilities were $2.9 billion (Q4 2025), $2.7 billion (Q3 2025), and $2.5 billion (Q2 2025) per Business Quant data.